天新药业: 2024年年度股东大会会议资料

Company Overview - Jiangxi Tianxin Pharmaceutical Co., Ltd. reported a revenue of 2.21 billion yuan in 2024, representing a year-on-year increase of 17.35% [27] - The net profit attributable to shareholders reached 651 million yuan, up 36.85% compared to the previous year [27] - The total assets of the company amounted to 5.60 billion yuan, reflecting a growth of 10.08% year-on-year [27] Industry Overview - The expected production of vitamins in China for 2024 is 420,000 tons, a decrease of 3.6% year-on-year, accounting for 85.9% of global production [14] - The market value of the vitamin industry in China is projected to be approximately 3.79 billion USD in 2024, with a growth of 1.4% [14] - Vitamin exports are anticipated to reach 332,000 tons, an increase of 5.6%, with export value expected to be 3.00 billion USD, up 11.1% [14] Company Operations - The company has focused on cost reduction, quality improvement, and efficiency enhancement across its operations, leading to a strengthened competitive position in the vitamin sector [15] - The company has optimized production processes and improved management levels, resulting in increased product yield and cost advantages [15] - The company achieved large-scale production of Vitamin B5 during the reporting period and is steadily advancing other investment projects [15] Corporate Governance - The company has established a governance structure comprising the shareholders' meeting, board of directors, supervisory board, and management, ensuring clear responsibilities and checks and balances [16] - The board of directors has conducted regular training to enhance compliance awareness and performance capabilities among directors and senior management [17] Financial Performance - The operating income for 2024 was 2.21 billion yuan, with a cost of sales of 1.28 billion yuan, leading to a gross profit margin improvement [29] - The company maintained stable expense levels across various categories, with a notable increase in research and development expenses [29][30] Future Outlook - The company plans to enhance product quality research, accelerate high-end market registrations, and explore new growth points in existing products [18] - The company aims to improve its digital transformation and smart manufacturing capabilities to enhance operational efficiency [19]